Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026GlobeNewsWire • 10/16/26
Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain RaceInvestorPlace • 10/09/26
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development ProgramGlobeNewsWire • 10/08/26
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® ProGlobeNewsWire • 09/29/26
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™GlobeNewsWire • 09/15/26
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European CitiesGlobeNewsWire • 09/09/26
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewsWire • 08/18/26
Quantum-Si Incorporated (QSI) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/13/26
Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development UpdateGlobeNewsWire • 08/13/26
Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026GlobeNewsWire • 07/27/26
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™Business Wire • 06/10/26
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks TranscriptSeeking Alpha • 05/15/26
Quantum-Si Incorporated (QSI) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/08/26
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development MilestonesBusiness Wire • 05/07/26
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQBusiness Wire • 05/01/26